BG
THC icon

Bellevue Group’s Tenet Healthcare THC Stock Holding History

Bellevue Group’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.27M Buy
38,868
+599
+2% +$110K 0.15% 75
2026
Q1 		$7.22M Sell
38,269
-1,970
-5% -$415K 0.17% 65
2025
Q4 		$8M Sell
40,239
-133
-0.3% -$26.9K 0.15% 69
2025
Q3 		$8.2M Buy
+40,372
New +$7.16M 0.17% 67
2025
Q2 		– Sell
-94,722
Closed -$12.7M – 153
2025
Q1 		$12.7M Sell
94,722
-15,508
-14% -$2.04M 0.29% 64
2024
Q4 		$13.9M Buy
110,230
+104,605
+1,860% +$15.6M 0.27% 72
2024
Q3 		$935K Buy
5,625
+211
+4% +$31.9K 0.02% 120
2024
Q2 		$720K Buy
5,414
+1,170
+28% +$141K 0.01% 124
2024
Q1 		$446K Buy
4,244
+2,797
+193% +$251K 0.01% 133
2023
Q4 		$109K Buy
1,447
+747
+107% +$47.4K ﹤0.01% 153
2023
Q3 		$46.1K Buy
700
+31
+5% +$2.32K ﹤0.01% 148
2023
Q2 		$54.4K Buy
+669
New +$47.6K ﹤0.01% 150
2018
Q1 		– Sell
-616,796
Closed -$9.34M – 134
2017
Q4 		$9.34M Hold
616,796
– – 0.98% 41
2017
Q3 		$10.1M Buy
616,796
+288,290
+88% +$4.89M 1.06% 34
2017
Q2 		$6.35M Buy
328,506
+2,960
+0.9% +$51.6K 0.75% 50
2017
Q1 		$5.77M Buy
+325,546
New +$6.04M 0.77% 45
2016
Q3 		– Sell
-10,000
Closed -$276K – 125
2016
Q2 		$276K Hold
10,000
– – 0.05% 116
2016
Q1 		$289K Buy
+10,000
New +$260K 0.05% 118

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bellevue Group's THC Position: Q2 2026 in Review

Bellevue Group increased its Tenet Healthcare (THC) stake by 1.6% in Q2 2026, buying an estimated $110K and bringing the position to 38,868 shares worth $7.27M. The position accounts for 0.15% of the portfolio, ranked #75.

Bellevue Group first reported a position in THC in Q1 2016 and has held it in 18 quarters since. The position peaked at $13.9M in Q4 2024. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Bellevue Group held 38,868 shares of Tenet Healthcare worth $7.27M as of Q2 2026.
  • Bellevue Group bought 599 Tenet Healthcare shares in Q2 2026, an estimated $110K.
  • Tenet Healthcare made up 0.15% of Bellevue Group's portfolio in Q2 2026, its #75 holding.
  • Bellevue Group first reported a position in Tenet Healthcare in Q1 2016 and has held it in 18 quarters since.
  • Bellevue Group's Tenet Healthcare position peaked at $13.9M in Q4 2024.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.